- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sun Pharma Advanced Research Company Ltd (SPRC)
Track today's live Sun Pharma Adv. Research (SPRC) share price, performance and key data on this page with our current NSE:SPRC stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Sun Pharma Adv. Research share price on the NSE exchange. Use the dropdown to switch exchange for the SPRC share price, head to our technical summary section, which provides analysis on Sun Pharma Adv. Research share price buy/sell indicators using real-time data (or discuss the Sun Pharma Adv. Research (SPRC) stock price today with other investors in the Sun Pharma Adv. Research NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:SPRC share price (ISIN: INE232I01014) to enhance your trading decisions with our free investment tools and resources.
What Is the Sun Pharma Advanced Research Company Ltd Share Price Today?
The Sun Pharma Adv. Research share price today is 223.38.
What Is the Stock Symbol for Sun Pharma Advanced Research Company Ltd
The stock symbol (or 'ticker') for Sun Pharma Advanced Research Company Ltd is "SPRC."
What Stock Exchange Does Sun Pharma Advanced Research Company Ltd Trade On?
Sun Pharma Advanced Research Company Ltd is listed and trades on the NSE stock exchange.
Is Sun Pharma Advanced Research Company Ltd a Good Stock to Buy?
Determining whether Sun Pharma Adv. Research (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:SPRC share price (ISIN: INE232I01014) to enhance your trading decisions with our free investment tools and resources.
What Is the Sun Pharma Advanced Research Company Ltd Share Price Today?
The Sun Pharma Adv. Research share price today is 223.38.
What Is the Stock Symbol for Sun Pharma Advanced Research Company Ltd
The stock symbol (or 'ticker') for Sun Pharma Advanced Research Company Ltd is "SPRC."
What Stock Exchange Does Sun Pharma Advanced Research Company Ltd Trade On?
Sun Pharma Advanced Research Company Ltd is listed and trades on the NSE stock exchange.
Is Sun Pharma Advanced Research Company Ltd a Good Stock to Buy?
Determining whether Sun Pharma Adv. Research (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
223.50
-4.01(-1.76%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
221.55
229.22
52 wk Range
108.00
289.00
SPRC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
221.55229.22
52 wk Range
108.00289.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SPRC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
2,000.00
Upside
+794.85%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 2,000.00
(+794.85% Upside)
Earnings
Latest Release
18/05/2026
EPS / Forecast
54.27 / --
Revenue / Forecast
18.55B / --
Compare SPRC to Peers and Sector
Metrics to compare | SPRC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPRCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 4.8x | 41.0x | −0.4x | |
PEG Ratio | 0.01 | 0.10 | 0.00 | |
Price/Book | 5.5x | 2.2x | 2.6x | |
Price / LTM Sales | 188.6x | 1.6x | 3.0x | |
Upside (Analyst Target) | - | 15.2% | 54.6% | |
Fair Value Upside | Unlock | 10.8% | 9.7% | Unlock |
Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. In addition, it develops SCD-153 for the treatment of alopecia areata; and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sun Pharma Adv. Research (NSE: SPRC) Share Price Today?
The Sun Pharma Adv. Research stock price today is 223.50 INR.
What Stock Exchange Does Sun Pharma Adv. Research (SPRC) Trade On?
Sun Pharma Adv. Research is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Sun Pharma Adv. Research?
The stock symbol (also called a 'ticker') for Sun Pharma Adv. Research is "SPRC."
What Is the Current Sun Pharma Adv. Research Market Capitalisation?
As of today, Sun Pharma Adv. Research (NSE: SPRC) market cap is 72.43B INR.
What Is Sun Pharma Adv. Research's (SPRC) Earnings Per Share (TTM)?
The Sun Pharma Adv. Research EPS is currently 47.86 (Trailing Twelve Months).
Is SPRC a Buy or Sell From a Technical Analyst Perspective?
Based on today's Sun Pharma Adv. Research moving averages and other technical indicators, the daily buy/sell signal for SPRC stock is Sell.
How Many Times Has Sun Pharma Adv. Research Stock Split?
Sun Pharma Adv. Research has split 2 times. (See the SPRC stock split history page for full effective split date and price information.)
How Many Employees Does Sun Pharma Adv. Research Have?
Sun Pharma Adv. Research has 316 employees, based on their latest Companies House report.
What is the current trading status of Sun Pharma Adv. Research (NSE: SPRC)?
As of 21/07/2026, Sun Pharma Adv. Research (SPRC) is trading at a share price of 223.50 INR, with a previous close of 227.51 INR. The stock has fluctuated within a day range of 221.55 INR to 229.22 INR, while its 52-week range spans from 108.00 INR to 289.00 INR.
What Is Sun Pharma Adv. Research (SPRC) Price Target According to Analysts?
The average 12-month price target for Sun Pharma Adv. Research is 2,000.00 INR, with a high estimate of 2000 INR and a low estimate of 2000 INR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +794.85% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.